alexa
Reach Us +1-217-403-9671
Good Automated Manufacturing Practice (GAMP) | 7583
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Good Automated Manufacturing Practice (GAMP)

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

K.Vaishnavi

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Abstract
Good Automated Manufacturing Practice (GAMP) is a trademark of the International Society for Pharmaceutical Engineering (ISPE). The program suggests and specifies various procedures to be used in all aspects of pharmaceutical production to make sure the end product is of the best quality possible. The Good Automated Manufacturing Practice is Guide for Validation of Automated Systems in Pharmaceutical Manufacturing. It describes a set of principles and procedures that help to ensure that pharmaceutical products have the required quality. One of the core principles of GAMP is that quality cannot be tested into a batch of product but must be built into each stage of the manufacturing process. As a result, GAMP covers all aspects of production; from the raw materials, facility and equipment to the training and hygiene of staff. Standard operating procedures (SOPs) are essential for processes that can affect the quality of the finished product. The improved GAMP guide offers a more flexible risk based approach to compliant GxP systems based on scale able specifications and verification. The first draft was issued for comment in 1994 and since then three subsequent revisions have been published as the GAMP guide to computer and automated system validation. Each addition has built on previous version adding details of best practice as they evolve. GAMP provides a documented assurance that a system is appropriate for the intended use before it goes ?live.? Suppliers can use GAMP to test for avoidable defects in the supplied system to ensure quality product leaves the facility. GAMP Version 1.0 was published in 1995 with follow-on versions in 1996, 1998 and finally 2001 for GAMP Version 4, so called GAMP4. GAMP5 was launched on 28th February 2008. It is a major rewrite of GAMP4 with significant changes having primary goals like bringing procedures in line with the dynamic life science industry and reducing the cost of compliance. This is one of the best parts of the guide as it has an in-built risk assessment. GAMP5 covers all aspects of pharmaceutical production, including materials, production procedures, equipment and hygienic issues. GAMP 5 is ?not a prescriptive method or standard, but rather provides pragmatic guidance, approaches and tools for the practitioners.
Biography
K. Vaishnavi is currently pursuing her 2nd year M. Pharmacy in Pharmaceutical Quality Assurance from JSS University, Mysore. She has done her graduation from Rajiv Gandhi University, Bangalore.She has attended 63rd IPC and presented a poster on ?GMP- A comparison between regulated and rest of the world countries? and also attended an International conference on ?Recent advances in pharmaceutical sciences? held by the Kathmandu University in Nepal and presented a poster on ?Good Laboratory Practice?.
Top